You have 0 free articles left this month.
Register for a free account to access unlimited free content.

Lawyers Weekly - legal news for Australian lawyers

Powered by MOMENTUM MEDIA
lawyers weekly logo

Powered by MOMENTUM MEDIA

Advertisement
Goodbye job applications, hello dream career
Seize control of your career and design the future you deserve with LW career

Ginkgo Bioworks, Microba Life Sciences enter development agreement

NYSE-listed Ginkgo Bioworks (NYSE: DNA) has entered into a technical development agreement with ASX-listed Microba Life Sciences (ASX: MAP).

user iconJerome Doraisamy 29 April 2022 Big Law
MinterEllison
expand image

Firm: MinterEllison (Ginkgo Bioworks)

Deal: The development agreement will facilitate Ginkgo and Microba’s collaboration on projects that develop live biotherapeutics for lupus, psoriatic arthritis and other autoimmune liver diseases – “all with the goal of improving treatment”, Minter said in a statement.

Area: Capital markets

Value: N/A

Key players: The Minter team was led by partner James Hutton, who was supported by corporate specialist Esmond Prowse and a cross-disciplinary MinterEllison team comprising specialists in intellectual property, tax, foreign investment, trade and transaction solutions.

Deal significance: Mr Hutton said: “We’re delighted to support Ginkgo in this transaction to help them work towards their collaboration and great health outcomes for the community.

The pandemic has continued to put a spotlight on the importance of life sciences and biotech for the wellbeing of the global community. Global partnerships like Ginkgo and Microba’s are a great example of how organisations are harnessing this to rapidly develop and improve diagnostics and treatment options.

“This also continues a theme of the growing importance of utilising computer power in life science platform technologies.”

Jerome Doraisamy

Jerome Doraisamy

Jerome Doraisamy is the managing editor of Lawyers Weekly and HR Leader. He is also the author of The Wellness Doctrines book series, an admitted solicitor in New South Wales, and a board director of the Minds Count Foundation.

You can email Jerome at: This email address is being protected from spambots. You need JavaScript enabled to view it. 

You need to be a member to post comments. Become a member for free today!